Jeeshan Chowdhury, MD, DPhil, is the CEO and Co-Founder of Journey Colab, a psychedelic biotech company on a mission to transform addiction treatment. He studied at Oxford University as a Rhodes Scholar and has founded multiple healthcare startups, including Listrunner (a Y Combinator-backed digital tool for clinical teams, acquired by Commure).

Chowdhury is spearheading cutting-edge research on psychedelic therapies for addiction. Through a first-of-its-kind partnership between Journey Colab and All Points North, he established the pioneering Center of Excellence to conduct clinical trials on psychedelics for alcohol use disorder in a real-world treatment setting.

An experienced entrepreneur and scholar, Chowdhury's work has been recognized globally. He has spoken at renowned conferences like the World Economic Forum and Aspen Ideas and was named a Top Healthcare Disruptor by Newsweek. His extensive experience pioneering new models of care uniquely qualifies him to share practical insights on preparing addiction treatment centers for the coming psychedelic therapy revolution.